dabigatran has been researched along with Eye Hemorrhage in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barequet, IS; Bourla, N; Moisseiev, J; Salomon, O; Tamarin, I; Zehavi-Dorin, T | 1 |
| Casson, RJ; Chan, W; Sanders, P; Selva, D; Sun, MT; Wong, CX; Wood, MK | 1 |
| Sun, MT; Wong, CX | 1 |
| Evans, J; Wormald, R | 1 |
| Miano, T; Pan, W; Uyhazi, KE; VanderBeek, BL | 1 |
| Bender, J; Bryant, G; Koenigsfeld, C; Lehman, N; Logemann, C; Sayler, M | 1 |
| Blum, RA; Lindfield, D | 1 |
| Etminan, M; Guo, M; Talany, G | 1 |
| Huff, CM; Nguyen, TM; Phelan, MP; Rychwalski, PJ; Werdich, XQ | 1 |
1 review(s) available for dabigatran and Eye Hemorrhage
| Article | Year |
|---|---|
Risk of Intraocular Bleeding With Novel Oral Anticoagulants Compared With Warfarin: A Systematic Review and Meta-analysis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Eye Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
8 other study(ies) available for dabigatran and Eye Hemorrhage
| Article | Year |
|---|---|
Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Blood Loss, Surgical; Dabigatran; Eye Hemorrhage; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Israel; Male; Middle Aged; Phacoemulsification; Postoperative Hemorrhage; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism | 2019 |
Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big Effect-Reply.
Topics: Anticoagulants; Dabigatran; Eye Hemorrhage; Humans | 2017 |
Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big Effect.
Topics: Anticoagulants; Dabigatran; Eye Hemorrhage; Humans; Warfarin | 2017 |
Association of Novel Oral Antithrombotics With the Risk of Intraocular Bleeding.
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Eye Hemorrhage; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Male; Pennsylvania; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Thromboembolism; Warfarin | 2018 |
Left subconjunctival hemorrhage · renal dysfunction · international normalized ratio of 4.5 · Dx?
Topics: Aged; Antithrombins; Atrial Fibrillation; Conjunctival Diseases; Dabigatran; Drug Interactions; Drug Substitution; Eye Hemorrhage; Female; Humans; Immunosuppressive Agents; International Normalized Ratio; Liver Transplantation; Renal Insufficiency; Tacrolimus; Treatment Outcome | 2015 |
Direct oral anticoagulant drugs (DOAC).
Topics: Administration, Oral; Anticoagulants; Antithrombins; Blood Loss, Surgical; Cataract Extraction; Dabigatran; Eye Hemorrhage; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridones; Rivaroxaban; Warfarin | 2016 |
Risk of intraocular hemorrhage with new oral anticoagulants.
Topics: Anticoagulants; Dabigatran; Eye Hemorrhage; Humans; Ocular Hypertension; Odds Ratio; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Warfarin | 2017 |
Subconjunctival hemorrhage in a patient on dabigatran (Pradaxa).
Topics: Acute Disease; Aged; Antithrombins; Benzimidazoles; Conjunctival Diseases; Dabigatran; Eye Hemorrhage; Humans; Male; Pyridines | 2013 |